The World Health Organization recommended Wednesday to continue using the AstraZeneca vaccine against Covid-19 "for the time being," pending the completion of its experts reviewing its safety data.

The organization indicated that its experts continue to "evaluate" the data on the health problems that some of the people who have received the vaccine have had.

The WHO did not say when its experts, who met on Tuesday, would release their conclusions.

The European Medicines Agency announced Tuesday that it was "completely convinced" of the benefits of the AstraZeneca vaccine and recommended that it continue to be used in vaccination campaigns.

About 15 countries, including Germany, France, Italy, Spain and Portugal, have suspended the use of the AstraZeneca vaccine as a precaution, after the emergence of serious blood problems such as blood clotting in some of those who received it.

At this time, there is no evidence that there is a link between these symptoms and the vaccine.

Dr. Anneliswilder Smith explained earlier during a press conference for the WHO committee that during clinical trials of the Johnson & Johnson vaccine against the Corona virus, ten patients from the group who received a placebo vaccine developed a blood clot, compared to 14 in a group who received the vaccine.

She noted that four people is not considered significant out of the 44,000 who participated in the experiment.